GOSS
Gossamer Bio Inc
10.70$
-2.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | -90.1% | -1.1% | +5.4% | +16.2% | +15.7% | +3.8% | +22.9% | -45.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1.8% | +1.3% | -2.4% | -14.4% | +0.2% | +1.0% | +1.2% | +1.5% | +1.0% | -4.3% | -8.6% | -2.0% | +0.6% | – | – | – | – | – | – | +2.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -117.1% | – | -90.1% | -1.1% | +5.4% | +16.2% | +15.7% | +3.8% | +21.2% | -44.8% | – | |
| – | – | +0.0% | +10,500.0% | +218.4% | +288.7% | +202.2% | +137.8% | +37.2% | -3.4% | +42.8% | +12.5% | +6.1% | -2.8% | -6.6% | +8.2% | -7.0% | +7.5% | +6.0% | -2.5% | -5.2% | +3.4% | +0.6% | +4.5% | -6.7% | -8.9% | -3.9% | -14.1% | -3.9% | +8.1% | +8.3% | -0.5% | +3.5% | +5.3% | +9.3% | +27.5% | -7.7% | -12.0% | -38.7% | – | |
| – | -82.5% | +0.0% | +424.1% | +106.6% | +1,558.6% | +76.9% | +397.3% | -39.2% | -42.3% | +20.4% | +1.7% | +17.8% | -7.3% | +8.4% | -1.8% | +38.7% | -28.5% | -0.7% | +10.6% | -14.0% | +12.0% | -6.0% | +2.0% | +11.6% | -21.1% | -1.5% | -6.9% | -2.5% | +5.6% | -9.4% | -1.9% | +10.5% | -7.8% | +0.2% | +8.2% | +16.1% | +71.9% | -52.5% | – | |
| – | – | +0.0% | +1,645.5% | +188.9% | +528.4% | +139.8% | +233.1% | -4.7% | -17.1% | +37.4% | +10.2% | +11.6% | -1.5% | +18.9% | -18.0% | +12.2% | -11.5% | +4.5% | +0.1% | -7.2% | +5.2% | -0.9% | +4.0% | -3.0% | -11.8% | -3.4% | -12.5% | +21.1% | -14.4% | +4.3% | -0.8% | +4.9% | +2.6% | +7.6% | +24.2% | -4.1% | +2.9% | -42.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -165.1% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -99.2% | +250.0% | -71.4% | +300.0% | +375.0% | – | – | – | +3,621.1% | +252.3% | +89.3% | +0.8% | +0.6% | +1.1% | +1.1% | +1.0% | -29.8% | +0.4% | -0.2% | -0.5% | +1.2% | -2.0% | -2.5% | -3.1% | -3.4% | -6.8% | -6.2% | +0.1% | +0.3% | -0.1% | +0.1% | +0.1% | +0.1% | -1.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -159.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -59.7% | -96.1% | +22.3% | +101.3% | – | – | – | +434.8% | -106.0% | – | +44.4% | +7.3% | -5.4% | -488.5% | – | -24.6% | +28.8% | -57.5% | +232.1% | +111.0% | -32.1% | -417.2% | – | – | -125.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -162.6% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -148.8% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.